Application of co-expressed genes to articular cartilage: New hope for the treatment of osteoarthritis (Review)

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 16-18

  Wan, Rong ^a   Hu, Jiong ^b   Zhou, Qi ^a   Wang, Jun ^a   Liu, Peiyi ^a   Wei, Yiyong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

2 macroglobulin; Articular cartilage; Chitosan mediated gene delivery; Osteoarthritis; Sox9

Indexed keywords

ADAMTS1 PROTEIN; ALPHA 2 MACROGLOBULIN; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRANSCRIPTION FACTOR SOX9;

ARTICULAR CARTILAGE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE DELIVERY SYSTEM; GENE TARGETING; GENE TRANSFER; HUMAN; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ADAM PROTEINS; ALPHA-MACROGLOBULINS; CARTILAGE, ARTICULAR; CHONDROGENESIS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GENE THERAPY; GLYCOPROTEINS; HUMANS; MATRIX METALLOPROTEINASES; OSTEOARTHRITIS; PHENOTYPE; SOX9 TRANSCRIPTION FACTOR;

EID: 84861640400     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.859     Document Type: Review

References (22)

1. Goldberg VM, Buckwalter J, Halpin M, et al: Recommendations of the OARSI FDA Osteoarthritis Devices Working Group. Osteoarthritis Cartilage 19: 509-514, 2011.
2. Rengel Y, Ospelt C and Gay S: Proteinases in the joint: Clinical relevance of proteinases in joint destruction. Arthritis Res Ther 9: 221, 2007.
3. Glasson SS, Askew R, Sheppard B, et al: Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434: 644-648, 2005. (Pubitemid 40488556)
4. Fosang AJ, Rogerson FM, East CJ and Stanton H: ADAMTS-5: the story so far. Eur Cell Mater 15: 11-26, 2008. (Pubitemid 351955729)
5. Malfait AM, Liu RQ, Ijiri K, Komiya S and Tortorella MD: Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 277: 22201-22208, 2002. (Pubitemid 34967185)
6. Luan Y, Kong L, Howell DR, et al: Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by α-2-macroglobulin. Osteoarthritis Cartilage 16: 1413-1420, 2008.
7. Burrage PS, Mix KS and Brinckerhoff CE: Matrix metalloproteinases: Role in arthritis. Front Biosci 11: 529-543, 2006.
8. Brighton CT, Wang W and Clark CC: The effect of electrical fields on gene and protein expression in human osteoarthritic cartilage explants. J Bone Joint Surg Am 90: 833-848, 2008. (Pubitemid 351499973)
9. Chu CT, Howard GC, Misra UK and Pizzo SV: α2-macroglobulin: a sensor for proteolysis. Ann NY Acad Sci 737: 291-307, 1994.
10. Tortorella MD, Arner EC, Hills R, et al: α2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes. J Biol Chem 279: 17554-17561, 2004. (Pubitemid 38560519)
11. Kuno K, Terashima Y and Matsushima K: ADAMTS-1 is an active metalloproteinase associated with the extracellular matrix. J Biol Chem 274: 18821-18826, 1999.
12. Beekman B, Drijfhout JW, Ronday HK and TeKoppele JM: Fluorogenic MMP activity assay for plasma including MMPs complexed to α2-macroglobulin. Ann NY Acad Sci 878: 150-158, 1999. (Pubitemid 29353567)
13. Tchetverikov I, Verzijl N, Huizinga TW, TeKoppele JM, Hanemaaijer R and DeGroot J: Active MMPs captured by α2 macroglobulin as a marker of disease activity in rheumatoid arthritis. Clin Exp Rheumatol 21: 711-718, 2003. (Pubitemid 38008753)
14. Hardingham TE, Oldershaw RA and Tew SR: Cartilage, SOX9 and Notch signals in chondrogenesis. J Anat 209: 469-480, 2006. (Pubitemid 44473315)
15. Haag J, Gebhard PM and Aigner T: SOX gene expression in human osteoarthritic cartilage. Pathobiology 75: 195-199, 2008.
16. Tew SR, Li Y, Pothacharoen P, Tweats LM, Hawkins RE and Hardingham TE: Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 13: 80-89, 2005. (Pubitemid 40104267)
17. Yang Z, Huang CY, Candiotti KA, et al: Sox-9 facilitates differentiation of adipose tissue-derived stem cells into a chondrocyte-like phenotype in vitro. J Orthop Res 29: 1291-1297, 2011.
18. Lee JS and Im GI: SOX trio decrease in the articular cartilage with the advancement of osteoarthritis. Connect Tissue Res: July 5, 2011 (Epub ahead of print).
19. Kofron MD and Laurencin CT: Orthopaedic applications of gene therapy. Curr Gene Ther 5: 37-61, 2005. (Pubitemid 40253501)
20. Hsieh JL, Shen PC, Shiau AL, et al: Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Hum Gene Ther 20: 147-158, 2009.
21. Gelse K, Muhle C, Franke O, et al: Cell-based resurfacing of large cartilage defects: long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. Arthritis Rheum 58: 475-488, 2008. (Pubitemid 351294882)
22. Zhang X, Yu C, Xushi, Zhang C, Tang T and Dai K: Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochem Biophys Res Commun 341: 202-208, 2006. (Pubitemid 43117405)